Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor-specific immunity in sarcoma patients.

W Rella, R Kotz, H Arbes

    Oncology
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Extendible Prostheses for Children After Resection of Primary Malignant Bone Tumor: Twenty-seven Years of Experience.

    The Journal of bone and joint surgery. American volume·2015
    Same author

    Pt nanoparticles supported on Sb-doped SnO₂ porous structures: developments and issues.

    Physical chemistry chemical physics : PCCP·2014
    Same author

    The pattern of the development of resistance and dependence to carbomycin in Micrococcus pyogenes var. aureus.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2012
    Same author

    The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.

    Annals of oncology : official journal of the European Society for Medical Oncology·2010
    Same author

    [Megaprostheses: KMFTR to GMRS].

    Der Orthopade·2010
    Same journal

    Real-World Outcomes in Acute Promyelocytic Leukemia: A 13-Year Cohort from Qatar.

    Oncology·2026
    Same journal

    SF3A3 in Liver Hepatocellular Carcinoma: Oncogenic Role and Prognostic Significance.

    Oncology·2026
    Same journal

    Letter to the Editor.

    Oncology·2026
    Same journal

    FLAG-Based Versus Standard 7+3 Induction Therapy in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.

    Oncology·2026
    Same journal

    Longitudinal Changes in Body Weight and Body Mass Index in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors: A Retrospective Observational Study.

    Oncology·2026
    Same journal

    Rising lung cancer burden attributable to high fasting plasma glucose in women aged ≥50 years: age-, SDI-, and BRICS-specific patterns from GBD 1990-2021.

    Oncology·2026
    See all related articles

    Immune responses to sarcoma cells correlate with patient prognosis. Higher immune stimulation suggests a better relapse-free interval and tumor-free survival in sarcoma patients.

    Area of Science:

    • Immunology
    • Oncology

    Background:

    • Investigating the role of tumor-associated immune responses in human sarcomas.
    • Correlating patient immune stimulation responses with clinical data and prognosis.

    Observation:

    • Patients with stimulation indices >1.5 showed a 22-month relapse-free interval, versus 5 months for indices <1.5.
    • 70% of responder patients were tumor-free at 1 year, compared to 26% of non-responders (p<0.05).
    • Tumor removal increased immune response and decreased blocking serum factors in patients with favorable prognoses.

    Findings:

    • Immune response levels returned to baseline in tumor-free patients 9-12 months post-surgery.
    • Lymphocyte stimulation by autologous tumor cells and cytotoxicity against allogeneic sarcoma cell lines were tested.
    • Discordant results between test systems were observed post-surgery, suggesting complementary diagnostic value.

    Related Experiment Videos

    Implications:

    • Tumor-associated immune responses appear to influence sarcoma development.
    • Immune response monitoring may aid in predicting sarcoma patient outcomes.
    • Combined immunological assays could clarify tumor-specific lymphocyte activities.